Use of the Novel Therapeutic Agent Miltefosine for the Treatment of Primary Amebic Meningoencephalitis: Report of 1 Fatal and 1 Surviving Case

Clinical Infectious Diseases

Volumn 62, Issue 6, 2015, Pages 774-776

  Cope, Jennifer R ^a   Conrad, Dennis A ^b   Cohen, Naiomi ^c   Cotilla, Manuel ^c   Dasilva, Alexandre ^a,d   Jackson, Jonathan ^a   Visvesvara, Govinda S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c MIAMI CHILDREN'S HOSPITAL   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Miltefosine; Naegleria fowleri; Primary amebic meningoencephalitis

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTICONVULSIVE AGENT; AZITHROMYCIN; CEFTRIAXONE; DEXAMETHASONE; FLUCONAZOLE; MANNITOL; MILTEFOSINE; RIFAMPICIN; SODIUM CHLORIDE; VANCOMYCIN; ANTIPROTOZOAL AGENT; PHOSPHORYLCHOLINE;

ANTICONVULSANT THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BRAIN DEATH; BRAIN DECOMPRESSION; BRAIN DISEASE; BRAIN EDEMA; BRAIN HERNIA; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID DRAINAGE; CHILD; CHILL; COMPUTER ASSISTED TOMOGRAPHY; CONSULTATION; DETERIORATION; FATALITY; FEVER; FOLLOW UP; GLASGOW COMA SCALE; HEADACHE; HUMAN; INDUCED HYPOTHERMIA; INTENSIVE CARE UNIT; INTRACRANIAL PRESSURE MONITORING; INTUBATION; LOADING DRUG DOSE; LUMBAR PUNCTURE; MALE; MENTAL DEFICIENCY; MENTAL INSTABILITY; NAEGLERIA FOWLERI; NAUSEA AND VOMITING; OUTCOME ASSESSMENT; PARASITE IDENTIFICATION; PEDIATRIC REHABILITATION; PHOTOPHOBIA; POLYMERASE CHAIN REACTION; PRIMARY AMEBIC MENINGOENCEPHALITIS; PRIORITY JOURNAL; SCHOOL CHILD; SEIZURE; SURVIVAL; TROPHOZOITE; VOMITING; WEAKNESS; ANALOGS AND DERIVATIVES; CENTRAL NERVOUS SYSTEM PROTOZOAL INFECTIONS; DIAGNOSTIC IMAGING; DRUG EFFECTS; ISOLATION AND PURIFICATION; MORTALITY; PARASITOLOGY; TREATMENT OUTCOME;

ANTIPROTOZOAL AGENTS; CENTRAL NERVOUS SYSTEM PROTOZOAL INFECTIONS; CHILD; FATAL OUTCOME; HUMANS; MALE; NAEGLERIA FOWLERI; PHOSPHORYLCHOLINE; TREATMENT OUTCOME;

EID: 84960078706     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ1021     Document Type: Article

References (11)

1. Capewell LG, Harris AM, Yoder JS, et al. Diagnosis, clinical course, and treatment of primary amoebic meningoencephalitis in the United States, 1937-2013. J Pediatric Infect Dis Soc 2015; 4:e68-75.
2. Anderson K, Jamieson A. Primary amoebic meningoencephalitis. Lancet 1972; 2:379.
3. Seidel JS, Harmatz P, Visvesvara GS, Cohen A, Edwards J, Turner J. Successful treatment of primary amebic meningoencephalitis. N Engl J Med 1982; 306:346-8.
4. Vargas-Zepeda J, Gomez-Alcala AV, Vasquez-Morales JA, Licea-Amaya L, De Jonckheere JF, Lares-Villa F. Successful treatment of Naegleria fowleri meningoencephalitis by using intravenous amphotericin B, fluconazole and rifampicin. Arch Med Res 2005; 36:83-6.
5. Linam WM, Ahmed M, Cope JR, et al. Successful treatment of an adolescent with Naegleria fowleri primary amebic meningoencephalitis. Pediatrics 2015; 135: e744-8.
6. Martinez DY, Seas C, Bravo F, et al. Successful treatment of Balamuthia mandrillaris amoebic infection with extensive neurological and cutaneous involvement. Clin Infect Dis 2010; 51:e7-11.
7. Sundar SS, Jha TK, Thakur CP, et al. Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med 2002; 347:1739-46.
8. Yoder JS, Straif-Bourgeois S, Roy SL, et al. Primary amebic meningoencephalitis deaths associated with sinus irrigation using contaminated tap water. Clin Infect Dis 2012; 55:e79-85.
9. Centers for Disease Control and Prevention. Notes from the field: primary amebic meningoencephalitis associated with ritual nasal rinsing-St. Thomas, U.S. Virgin islands, 2012. MMWR Morb Mortal Wkly Rep 2013; 62:903.
10. Cope JR, Ratard RC, Hill VR, et al. The first association of a primary amebic meningoencephalitis death with culturable Naegleria fowleri in tap water from a US treated public drinking water system. Clin Infect Dis 2015; 60:e36-42.
11. Centers for Disease Control and Prevention. Investigational drug available directly from CDC for the treatment of infections with free-living amebae. MMWR Morb Mortal Wkly Rep 2013; 62:666.